Evaluation of ADG20 for the Prevention of COVID-19

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

NCT04405570 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19

NCT04385849 ·Status: TERMINATED ·Phase: PHASE1

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

NCT04328285 ·Status: TERMINATED ·Phase: PHASE3

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541 ·Status: TERMINATED ·Phase: PHASE3

Trial of Combination Therapy to Treat COVID-19 Infection

NCT04482686 ·Status: COMPLETED ·Phase: PHASE1

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

NCT04634799 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

ACTIV-3: Therapeutics for Inpatients With COVID-19

NCT04501978 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection

NCT04488575 ·Status: TERMINATED ·Phase: PHASE2

COVID-19 and Anti-CD14 Treatment Trial

NCT04391309 ·Status: TERMINATED ·Phase: PHASE2

AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

NCT04507256 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780463 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

NCT05305547 ·Status: COMPLETED ·Phase: PHASE3

The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

NCT04405739 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 ·Status: COMPLETED ·Phase: PHASE2

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

NCT04828161 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

NCT04569227 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

NCT04396106 ·Status: TERMINATED ·Phase: PHASE2

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

NCT05642910 ·Status: UNKNOWN ·Phase: NA

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

NCT04405076 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Trial of Remdesivir in Adults With Severe COVID-19

NCT04257656 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

NCT04439071 ·Status: TERMINATED ·Phase: PHASE2/PHASE3